Angle-closure glaucoma secondary to ciliary body swelling.
D000086:Acetazolamide / Q000627:therapeutic use; D000328:Adult; D000867:Anterior Chamber / Q000473:pathology; D001285:Atropine / Q000627:therapeutic use; D001623:Betamethasone / Q000627:therapeutic use; D002924:Ciliary Body / Q000473:pathology*; D003345:Corticosterone / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D005901:Glaucoma / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D005990:Glycerol / Q000627:therapeutic use; D006801:Humans; D007429:Intraocular Pressure; D007909:Lenses / Q000009:adverse effects; D008297:Male; D009184:Mydriatics / Q000627:therapeutic use; D010656:Phenylephrine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013997:Time Factors; D014792:Visual Acuity
D009184:Mydriatics; D010656:Phenylephrine; D001285:Atropine; D003907:Dexamethasone; D001623:Betamethasone; D000086:Acetazolamide; D005990:Glycerol; D011241:Prednisone; D003345:Corticosterone